Geriatric COVID-19 Serology

• Conditions: COVID-19

• Registration Number: NCT05109546
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Coronaviruses are important human and animal pathogens. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in China's Hubei province. It quickly spread, leading to an epidemic across China, followed by an increasing number of cases in other countries around the world. In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019. The virus that causes COVID-19 is SARS-CoV-2.

The duration of protection during which a patient after infection and / or vaccination remains clinically protected and the evolution of their serology as well as their titre remains unknown

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-15
• Status Verified: 2021-11
• Study First Submitted: 2021-11-04
• Study First Submitted QC: 2021-11-04
• Study First Posted: 2021-11-05
• Last Update Submitted: 2021-11-09
• Last Update Posted: 2021-11-17
• Primary Completion: 2022-03
• Study Completion: 2022-03-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective study of COVID serologies in a geriatric population after infection or vaccination	Files analysed retrospectively from July 1, 2020 to November 30, 2021 will be examined]

Trial Locations

Locations (1)

Service SSR Gériatrique - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France